Hydrochlorthiazide

Hydrochlorthiazide

SCHEMBL2498526

[LiH].c1cscn1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113264902-A Synthesis production process of lithium thiazole 南京爱可德夫科技开发有限公司 2021-08-17 CN claimed
JP-10045732-A None JP disclosed
CN-116554121-A Synthesis method of 2-isobutyl thiazole 济南悟通生物科技有限公司 2023-08-08 CN disclosed
CN-219400107-U Synthesis system of 2-acetyl thiazole 济南悟通生物科技有限公司 2023-07-25 CN disclosed
CN-219400107-U Synthesis system of 2-acetyl thiazole 济南悟通生物科技有限公司 2023-07-25 CN disclosed
US-11691959-B2 Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds AVEXXIN AS (NO) 2023-07-04 US disclosed
CN-112898226-B Preparation method of 2-alkyl substituted thiazole compound 济南悟通生物科技有限公司 2023-02-24 CN disclosed
US-20220363659-A1 ANTI-INFLAMMATORY AND ANTITUMOR 2-OXOTHIAZOLES AND 2-OXOTHIOPHENES COMPOUNDS AVEXXIN AS (NO) 2022-11-17 US disclosed
CN-107074840-B 2-oxothiazole compounds having activity as cPLA2 inhibitors for the treatment of inflammatory and hyperproliferative diseases 埃维克辛公司 2022-04-26 CN disclosed
CN-113264902-A Synthesis production process of lithium thiazole 南京爱可德夫科技开发有限公司 2021-08-17 CN disclosed
CN-1121379-C Synthesis and use of retinoid having negative hormone and/or antagonist activity ALLERGAN CO (US) 2003-09-17 CN disclosed
CN-1360890-A Use of active retiene derivative with negative hormone and/or antagonist ALLERGAN INC (US) 2002-07-31 CN disclosed
CN-1268130-A Synthesis and use of retinol derivative compounds having negative hormone and/or antagonist activity ALLERGAN SALES INC (US) 2000-09-27 CN disclosed
US-6124291-A TREATING AND PREVENTING THROMBOTIC DISORDERS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
CN-1212705-A Serine protease inhibitors AKZO NOBEL NV (NL) 1999-03-31 CN disclosed
CN-1209802-A Synthesis and use of retinoid having negative hormone and/or antagonist activity ALLERGAN CO (US) 1999-03-03 CN disclosed
EP-0846120-A1 LOW MOLECULAR WEIGHT BICYCLIC-AREA TYPE THROMBIN INHIBITORS BIOCHEM PHARMA INC (CA) 1998-06-10 EP disclosed
JP-H1045732-A DIARYLETHENE DERIVATIVE AND PHOTOCHROMIC MATERIAL USING THE SAME IRIE MASAHIRO 1998-02-17 JP disclosed
WO-1997048706-A1 PYRROLO[1,2-A]PYRAZINE-1,4-DIONE SERINE PROTEASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1997-12-24 WO disclosed
WO-1996037497-A1 LOW MOLECULAR WEIGHT BICYCLIC-UREA TYPE THROMBIN INHIBITORS BIOCHEM PHARMA INC. (CA) 1996-11-28 WO disclosed